Ideal to transfect primary and hard-to-transfect cells, Magnetofectamine™ associates Lipofectamine™ 2000 from Invitrogen™ and Oz Biosciences's CombiMag reagent, increasing the overall efficiency of your transfection while minimising cytotoxicity. Lipofectamine™ 2000 is the leading transfection reagent on the market for simple and effective nucleic acid delivery; CombiMag is a Magnetofection™ based reagent: versatile and improving transfection efficiency without toxicity.

• Superior transfection efficiency
• Enhanced Lipofectamine™ 2000 efficiency
• Ideal for hard-to-transfect and primary cells
• Less nucleic acids used - minimized toxicity
• Serum compatible and applicable to all nucleic acids
• Simple, ready-to use and rapid - No need to change your standard Lipofectamine™ 2000 protocol